Menard Financial Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,032
Closed -$305K 107
2025
Q1
$305K Buy
2,032
+75
+4% +$12.5K 0.2% 82
2024
Q4
$319K Buy
1,957
+201
+11% +$35.9K 0.19% 92
2024
Q3
$343K Buy
+1,756
New +$324K 0.23% 91
2022
Q2
Sell
-6,026
Closed -$1.14M 133
2022
Q1
$1.14M Buy
6,026
+987
+20% +$195K 1.12% 17
2021
Q4
$1.23M Buy
5,039
+1,286
+34% +$282K 1.01% 20
2021
Q3
$729K Buy
3,753
+421
+13% +$85K 0.64% 35
2021
Q2
$621K Buy
3,332
+199
+6% +$34.6K 0.59% 44
2021
Q1
$493K Sell
3,133
-429
-12% -$68K 0.53% 53
2020
Q4
$590K Buy
3,562
+259
+8% +$42.1K 0.63% 42
2020
Q3
$546K Buy
3,303
+257
+8% +$39.5K 0.63% 38
2020
Q2
$417K Buy
+3,046
New +$398K 0.52% 41
2020
Q1
Sell
-5,297
Closed -$701K 124
2019
Q4
$701K Buy
+5,297
New +$658K 0.67% 48

Other funds holding ZTS

Menard Financial Group's ZTS Position: Q2 2025 in Review

Menard Financial Group sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 2,032 shares — an estimated $305K sold.

Menard Financial Group first reported a position in ZTS in Q4 2019 and held it in 12 quarters. The position peaked at $1.23M in Q4 2021. 1,871 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Menard Financial Group reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Menard Financial Group sold 2,032 Zoetis shares in Q2 2025, an estimated $305K.
  • Menard Financial Group first reported a position in Zoetis in Q4 2019 and held it in 12 quarters.
  • Menard Financial Group's Zoetis position peaked at $1.23M in Q4 2021.
  • 1,871 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Menard Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.